Contact Us: 01282 426380
KM Financial Solutions | China’s Innovent Biologics looks to raise up to $422 mln in HK IPO – sources
32117
post-template-default,single,single-post,postid-32117,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

China’s Innovent Biologics looks to raise up to $422 mln in HK IPO – sources

14 Oct China’s Innovent Biologics looks to raise up to $422 mln in HK IPO – sources

Posted at 05:52h in News by
0 Likes
Chinese biotech firm Innovent
Biologics is looking to raise up to $422 million in its Hong
Kong IPO, three sources said, in what could be the biggest
biotech IPO in the financial hub this year.

No Comments

Sorry, the comment form is closed at this time.